Expert opinion on the use of contraception in people with multiple sclerosis

Author:

Hillert Jan1ORCID,Bove Riley2ORCID,Haddad Lisa B3,Hellwig Kerstin4ORCID,Houtchens Maria5ORCID,Magyari Melinda6,Merki-Feld Gabriele S7,Montgomery Scott18,Nappi Rossella E910,Stenager Egon1112,Thompson Heidi13,Tulek Zeliha14,Verdun Di Cantogno Elisabetta15,Simoni Manuela16

Affiliation:

1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

2. UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA

3. Center for Biomedical Research, Population Council, New York, NY, USA

4. Katholisches Klinikum Bochum GmbH, Nordrhein-Westfalen, Bochum, Germany

5. Brigham and Women’s Hospital, Boston, MA, USA/ Harvard Medical School, Boston, MA, USA

6. Danish Multiple Sclerosis Center, University Hospital Boston, MA, USA/ Rigshospitalet, Copenhagen, Denmark

7. Clinic of Reproductive Endocrinology, University Hospital Zürich, Zürich, Switzerland

8. Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

9. Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy

10. Research Center of Reproductive Medicine, IRCCS San Matteo Foundation, Pavia, Italy

11. Department of Regional Research, University of Southern Denmark, Odense, Denmark

12. MS-Clinic of Southern Jutland (Aabenraa, Esbjerg, Kolding), Sønderborg, Denmark

13. Southern Health & Social Care Trust, Portadown, Northern Ireland

14. Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing, Istanbul University-Cerrahpasa, Istanbul, Turkey

15. EMD Serono Research & Development Institute, Inc., Billerica, MA, USA

16. Unit of Endocrinology, Department of Medical Specialties, University Hospital and Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

Abstract

Background: Current guidance on the selection of appropriate contraception for people with multiple sclerosis (PwMS) is lacking. Objective: To address this gap, an expert-led consensus program developed recommendations to support clinicians in discussing family planning and contraception with women and men with multiple sclerosis (MS). Methods: A multidisciplinary steering committee (SC) of 13 international clinical experts led the program, supported by an extended faculty of 32 experts representing 18 countries. A modified Delphi methodology was used for decision-making and consensus-building. The SC drafted 15 clinical questions focused on patient-centered care, selection of contraception, and timing of stopping/starting contraception and disease-modifying therapies (DMTs). Statements addressing each question were drafted based on evaluation of published evidence and the experts’ clinical experience. Consensus was reached if ⩾75% of respondents agreed (scoring 7–9 on a 9-point scale) with each recommendation. Results: Consensus was reached on 24 of 25 proposed recommendations, including how and when to discuss contraception, types and safety of contraceptives, and how to evaluate the most appropriate contraceptive options for specific patient groups, including those with significant disability or being treated with DMTs. Conclusion: These expert recommendations provide the first practical, relevant, and comprehensive guidance for clinicians on the selection of contraception in PwMS.

Funder

Merck

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3